CD274 and salivary duct carcinoma: Salivary duct carcinoma appears to have a favorable immunogenic profile characterized by a moderate tumor mutation burden and medium or high inflammation in the microenvironment [14], and several studies have shown that salivary duct carcinoma has high PD‐L1 expression [15, 16, 17, 18, 19, 20, 21].